| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
215,990 | 279,418 | 263,860 | 236,923 | 21,662 |
| Cost of Revenue
|
-261,906 | -304,267 | -267,054 | -252,974 | -77,643 |
|
Gross Profit
|
-45,916 | -24,849 | -3,194 | -16,051 | -55,981 |
| Selling, General and Administrative Expenses
|
-8,368 | -7,880 | -7,011 | -7,534 | -7,620 |
| Provision Expense/Write-Back
|
-- | -- | -- | 0 | -358 |
| Other Income/Expense, Operating
|
170 | -- | -- | -- | -- |
|
Operating Income/Expenses
|
-8,198 | -7,880 | -7,011 | -7,534 | -7,978 |
|
Total Operating Profit/Loss
|
-54,114 | -32,729 | -10,205 | -23,585 | -63,959 |
| Total Net Finance Income/Expense
|
-31,456 | -54,723 | -53,662 | -44,162 | -27,503 |
| Net Investment Income
|
-2,028 | 44 | 610 | -389 | -1,040 |
| Irregular Income/Expenses
|
-13,130 | -13,130 | -- | -- | -- |
|
Non-Operating Income/Expenses, Total
|
-46,614 | -67,809 | -53,052 | -44,551 | -28,543 |
|
Pretax Income
|
-100,728 | -100,538 | -63,257 | -68,136 | -92,502 |
|
Provision for Income Tax
|
-1,247 | -2,127 | -2,400 | -2,762 | -388 |
|
Net Income from Continuing Operations
|
-101,975 | -102,665 | -65,657 | -70,898 | -92,890 |
|
Other Net of Taxes Adjustments
|
-- | -- | -- | -- | 0 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-101,975 | -102,665 | -65,657 | -70,898 | -92,890 |
|
Net Income after Non-Controlling/Minority Interests
|
-101,975 | -102,665 | -65,657 | -70,898 | -92,890 |
|
Net Income Available to Common Stockholders
|
-101,975 | -102,665 | -65,657 | -70,898 | -92,890 |
|
Diluted Net Income Available to Common Stockholders
|
-101,975 | -102,665 | -65,657 | -70,898 | -92,890 |
| Basic EPS
|
-0.34 | -0.34 | -0.23 | -0.39 | -0.80 |
| Diluted EPS
|
-0.34 | -0.34 | -0.23 | -0.39 | -0.80 |
|
Basic Weighted Average Shares Outstanding
|
303,214.80 | 303,215 | 283,071 | 182,500 | 115,494 |
|
Diluted Weighted Average Shares Outstanding
|
303,214.80 | 303,215 | 283,071 | 182,500 | 115,494 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-69,303 | -45,848 | -9,636 | -23,981 | -65,010 |
|
EBITDA
|
-26,461 | 9,286 | 40,293 | 18,908 | -24,801 |
|
Normalized EBITDA
|
-12,564 | 23,966 | 40,622 | 18,943 | -24,600 |
|
Normalized Income
|
-90,162.55 | -90,187 | -65,328 | -70,863 | -92,689 |
|
Total Unusual Items
|
13,897 | 14,680 | 329 | 35 | 201 |
12/31/2022 - 2/27/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade